AllSquare Wealth Management’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.65K Hold
475
﹤0.01% 469
2025
Q2
$1.04K Hold
475
﹤0.01% 484
2025
Q1
$551 Hold
475
﹤0.01% 503
2024
Q4
$603 Sell
475
-150
-24% -$382 ﹤0.01% 498
2024
Q3
$2.13K Hold
625
﹤0.01% 467
2024
Q2
$2.92K Hold
625
﹤0.01% 449
2024
Q1
$4.64K Hold
625
﹤0.01% 428
2023
Q4
$6.33K Hold
625
﹤0.01% 403
2023
Q3
$4.88K Sell
625
-900
-59% -$7.72K ﹤0.01% 423
2023
Q2
$13.7K Hold
1,525
0.01% 344
2023
Q1
$11.1K Hold
1,525
0.01% 362
2022
Q4
$13.5K Hold
1,525
0.01% 329
2022
Q3
$19K Hold
1,525
0.01% 282
2022
Q2
$18K Hold
1,525
0.01% 301
2022
Q1
$29K Hold
1,525
0.02% 273
2021
Q4
$40K Sell
1,525
-40
-3% -$1.38K 0.02% 247
2021
Q3
$64K Hold
1,565
0.04% 194
2021
Q2
$89K Sell
1,565
-300
-16% -$11.1K 0.05% 173
2021
Q1
$78K Buy
1,865
+400
+27% +$22.8K 0.05% 174
2020
Q4
$103K Sell
1,465
-210
-13% -$8.63K 0.07% 137
2020
Q3
$47K Buy
1,675
+23
+1% +$749 0.03% 194
2020
Q2
$49K Buy
1,652
+977
+145% +$25.5K 0.04% 181
2020
Q1
$13K Hold
675
0.01% 274
2019
Q4
$20K Hold
675
0.01% 262
2019
Q3
$15K Buy
675
+50
+8% +$1.24K 0.01% 285
2019
Q2
$15K Hold
625
0.01% 294
2019
Q1
$15K Buy
625
+600
+2,400% +$13.6K 0.01% 288
2018
Q4
$1K Hold
25
﹤0.01% 439
2018
Q3
$1K Hold
25
﹤0.01% 458
2018
Q2
$1K Hold
25
﹤0.01% 466
2018
Q1
$1K Sell
25
-25
-50% -$891 ﹤0.01% 380
2017
Q4
$2K Sell
50
-101
-67% -$2.54K ﹤0.01% 352
2017
Q3
$4K Buy
+151
New +$2.87K ﹤0.01% 312

Other funds holding EDIT

AllSquare Wealth Management's EDIT Position: Q3 2025 in Review

AllSquare Wealth Management held its Editas Medicine (EDIT) position steady in Q3 2025 at 475 shares worth $1.65K. The position accounts for ﹤0.01% of the portfolio, ranked #469.

AllSquare Wealth Management first reported a position in EDIT in Q3 2017 and has held it in 33 quarters since. The position peaked at $103K in Q4 2020. 193 funds tracked by Wall St. Rank hold EDIT as of Q3 2025.

  • AllSquare Wealth Management held 475 shares of Editas Medicine worth $1.65K as of Q3 2025.
  • AllSquare Wealth Management left its Editas Medicine share count unchanged in Q3 2025.
  • Editas Medicine made up ﹤0.01% of AllSquare Wealth Management's portfolio in Q3 2025, its #469 holding.
  • AllSquare Wealth Management first reported a position in Editas Medicine in Q3 2017 and has held it in 33 quarters since.
  • AllSquare Wealth Management's Editas Medicine position peaked at $103K in Q4 2020.
  • 193 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2025.

Based on AllSquare Wealth Management's 13F filing for Q3 2025, filed 12 Jan 2026.